| 注册
首页|期刊导航|中国社区医师|前列地尔治疗高龄糖尿病合并慢性肾脏病患者疗效和安全性评价

前列地尔治疗高龄糖尿病合并慢性肾脏病患者疗效和安全性评价

龙艳菲

中国社区医师2016,Vol.32Issue(33):28-28,30,2.
中国社区医师2016,Vol.32Issue(33):28-28,30,2.DOI:10.3969/j.issn.1007-614x.2016.33.13

前列地尔治疗高龄糖尿病合并慢性肾脏病患者疗效和安全性评价

Efficacy and safety of alprostadil in the treatment of elderly patients with diabetes and chronic kidney disease

龙艳菲1

作者信息

  • 1. 200333上海市利群医院药剂科
  • 折叠

摘要

Abstract

Objective:To explore the efficacy and safety of alprostadil in the treatment of elderly patients with diabetes and chronic kidney disease.Methods:96 elderly patients with diabetes and chronic kidney disease were selected.They were randomly divided into the control group and the experimental group.The control group was treated with conventional therapy.The experimental group was treated with alprostadil.We compared the therapeutic effect of two groups.Results:After treatment,in the experimental group,blood urea nitrogen,serum creatinine,24 hours urinary protein and adverse reaction rates were better than the control group(P<0.05).Conclusion:The efficacy of alprostadil in the treatment of elderly patients with diabetes and chronic kidney disease was significant,and the safety was high.

关键词

糖尿病合并慢性肾脏病/高龄/前列地尔/安全性

Key words

Diabetes mellitus complicated with chronic kidney disease/Elderly/Alprostadil/Safety

引用本文复制引用

龙艳菲..前列地尔治疗高龄糖尿病合并慢性肾脏病患者疗效和安全性评价[J].中国社区医师,2016,32(33):28-28,30,2.

中国社区医师

1007-614X

访问量6
|
下载量0
段落导航相关论文